TAR-regulated reverse transcripition in HIV-1.
TAR-regulated reverse transcripition in HIV-1.
批准号:
nhmrc : 290260
负责人:
A/Pr David Harrich
金额:
$16.95万
依托单位国家:
澳大利亚
项目类别:
NHMRC Project Grants
财政年份:
2004
资助国家:
澳大利亚
项目状态:
已结题
起止时间:
2004-01-01 至 2006-12-31
中文摘要
点击翻译按钮获取中文摘要
英文摘要
During reverse transcription, the positive-strand HIV-1 RNA genome is converted into a double-stranded DNA copy which can be permanently insert into the host cell genome. Our laboratory and others have shown that reverse transcription requires a complex array of molecules, which includes the viral RNA. These RNA can be organised into elaborate structures that have only been partially defined. Genetic experiments have revealed that one of these RNA structures, called TAR, is required for optimal initiation of reverse transcription (the first step of reverse transcription), but the precise mechanism is unknown. Recent advances in our laboratory have enabled a comprehensive study of the role played by TAR RNA in reverse transcription. Our leading hypotheses regarding the mechanism is required that TAR interacts with other RNA sequences or Reverse transcriptase in the initiation complex so that the reaction is optimal. This proposal will investigate these two leading hypotheses. Given the enormity of the HIV pandemic and the many recent reports from the United States that most patient isolated virus is resistant to at least one antiretroviral drug, these studies have as an outcome the identification and characterisation of important new key molecules towards which antiretroviral strategies can be designed.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
A potent anti-HIV-1 gene therapy agent in a humanised mouse model
-
批准号:nhmrc : 1085359
-
项目类别:Project Grants
-
资助金额:$76.49万
-
财政年份:2015
-
负责人:A/Pr David Harrich
-
依托单位:
A potent anti-HIV-1 gene therapy agent in a humanised mouse model
-
批准号:nhmrc : GNT1085359
-
项目类别:Project Grants
-
资助金额:$110.11万
-
财政年份:2015
-
负责人:A/Pr David Harrich
-
依托单位:
eEF1A1 is critical for HIV-1 reverse transcription and replication
-
批准号:nhmrc : 1080465
-
项目类别:Project Grants
-
资助金额:$34.77万
-
财政年份:2015
-
负责人:A/Pr David Harrich
-
依托单位:
The Human Eukaryotic Translation Elongation Factor 1A is a Paramyxovirus Virus Dependency Factor
-
批准号:nhmrc : 1065121
-
项目类别:Project Grants
-
资助金额:$39.04万
-
财政年份:2014
-
负责人:A/Pr David Harrich
-
依托单位:
An RNA Element Negatively Regulates Initation HIV-1 Reverse transcription and Inhibits Proviral Integration
-
批准号:nhmrc : 1004715
-
项目类别:NHMRC Project Grants
-
资助金额:$38.78万
-
财政年份:2011
-
负责人:A/Pr David Harrich
-
依托单位:
How Does A Host Cell Stimulatory Factor Stabilize The HIV-1 Reverse Transcription Complex?
-
批准号:nhmrc : 1002440
-
项目类别:NHMRC Project Grants
-
资助金额:$42.13万
-
财政年份:2011
-
负责人:A/Pr David Harrich
-
依托单位:
Regulation of HIV-1 Tat Trafficking in cells
-
批准号:nhmrc : 552419
-
项目类别:NHMRC Project Grants
-
资助金额:$32.97万
-
财政年份:2009
-
负责人:A/Pr David Harrich
-
依托单位:
HOST CELL FACTORS INCREASE THE EFFICIENCY OF HIV-1 REVERSE TRANSCRIPTION
-
批准号:nhmrc : 496663
-
项目类别:NHMRC Project Grants
-
资助金额:$42.47万
-
财政年份:2008
-
负责人:A/Pr David Harrich
-
依托单位:
The HIV-1 Tat protein is an reverse transcription co-factor.
-
批准号:nhmrc : 389826
-
项目类别:NHMRC Project Grants
-
资助金额:$26.98万
-
财政年份:2006
-
负责人:A/Pr David Harrich
-
依托单位:
Kunjin replicon based vaccines for HIV
-
批准号:nhmrc : 290240
-
项目类别:NHMRC Project Grants
-
资助金额:$22.93万
-
财政年份:2004
-
负责人:A/Pr David Harrich
-
依托单位:
Viral and cellular factors affecting early steps in HIV reverse transcription
-
批准号:nhmrc : 298926
-
项目类别:NHMRC Project Grants
-
资助金额:$31.06万
-
财政年份:2004
-
负责人:A/Pr David Harrich
-
依托单位:
The mechanism of Tat-enhanced reverse transcription in HIV-1
-
批准号:nhmrc : 252846
-
项目类别:NHMRC Project Grants
-
资助金额:$18.85万
-
财政年份:2003
-
负责人:A/Pr David Harrich
-
依托单位:
国内基金
海外基金
登录
查看更多内容
Myostatin调控的miRNAs在骨骼肌发育中的功能及表达调控的分子机制
-
批准号:31030041
-
项目类别:重点项目
-
资助金额:210.0万元
-
批准年份:2010
-
负责人:朱大海
-
依托单位:
Myostatin调节的miRNAs基因在骨骼肌发育和肌干细胞激活中的表观遗传调控
-
批准号:91019010
-
项目类别:重大研究计划
-
资助金额:55.0万元
-
批准年份:2010
-
负责人:张勇
-
依托单位:
Dyrk1A调控CaMKⅡδ的可变剪接及其在心脏重构过程中的作用
-
批准号:30971223
-
项目类别:面上项目
-
资助金额:31.0万元
-
批准年份:2009
-
负责人:朱健华
-
依托单位:
Cart基因保护缺血性脑损害及其分子机制的研究
-
批准号:30470612
-
项目类别:面上项目
-
资助金额:22.0万元
-
批准年份:2004
-
负责人:徐运
-
依托单位: